Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
interferon beta-1b (betaseron) (1 trial)
naltrexone (revia) (1 trial)
Multiple Sclerosis (Phase 4)
Sclerosis (Phase 4)
Trials (1 total)
Trial APIs (2 total)